SCHEMBL12377852

SCHEMBL12377852

COC(=O)c1coc(-c2cccc(C)c2)n1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 7/20 0.51
HDAC8 Q9BY41 7/20 0.51
HDAC6 Q9UBN7 7/20 0.51
PDE4B Q07343 6/20 0.49
ALDH1A1 P00352 1/20 0.46
PPARA Q07869 1/20 0.45
SCN10A Q9Y5Y9 1/20 0.44
NPC1 O15118 1/20 0.44
TP53 P04637 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
ROCK2 O75116 1/20 0.44
HSD17B10 Q99714 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1544536 0.85 HDAC1 (0.50) HDAC1HDAC8HDAC6PDE4BALDH1A1
SCHEMBL3912093 0.85 HDAC1 (0.50) HDAC1HDAC8HDAC6PDE4BALDH1A1
SCHEMBL12522679 0.85 HDAC1 (0.53) HDAC1HDAC8HDAC6PDE4BALDH1A1
SCHEMBL10029551 0.84 HDAC1 (0.51) HDAC1HDAC8HDAC6PDE4BALDH1A1
SCHEMBL6386434 0.84 HDAC1 (0.65) HDAC1HDAC8HDAC6PDE4BALDH1A1
SCHEMBL6438024 0.84 HDAC1 (0.52) HDAC1HDAC8HDAC6PDE4BALDH1A1
SCHEMBL12377859 0.83 HDAC1 (0.58) HDAC1HDAC8HDAC6PDE4BALDH1A1
SCHEMBL9900075 0.83 ALDH1A1 (0.68) HDAC1HDAC8HDAC6PDE4BALDH1A1
SCHEMBL6437647 0.83 HDAC1 (0.48) HDAC1HDAC8HDAC6PDE4BALDH1A1
SCHEMBL21689281 0.82 HDAC1 (0.68) HDAC1HDAC8HDAC6PDE4BALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7998954-B2 Pyrimidodiazepinone derivative KYOWA HAKKO KIRIN CO., LTD. (JP) 2011-08-16 US disclosed
US-20100190775-A1 PYRIMIDODIAZEPINONE DERIVATIVE KYOWA HAKKO KIRIN CO., LTD (JP) 2010-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100190775-A1 PYRIMIDODIAZEPINONE DERIVATIVE KCNJ1, KCNJ11, ADRA1D HDAC1 120/4885HDAC8 462/4885HDAC6 443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.